Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics to Profile Samples for Centocor to Identify Cancer Biomarkers

NEW YORK (GenomeWeb News) — Epigenomics yesterday said it will help Johnson & Johnson unit Centocor identify and analyze cancer-related biomarkers.
 
Under the agreement, Epigenomics will use its Differential Methylation Hybridization microarray to profile samples with the aim selecting patients who are more likely to benefit from one of Centocor’s candidate drugs.
 
Financial terms of the agreement were not disclosed.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.